Investigating the ultrastructure of platelets of HIV patients treated with the immuno-regulator, Canova: A qualitative scanning electron microscopy study

Histology and Histopathology

Volumn 24, Issue 4, 2009, Pages 399-405

  Pretorius, E ^a   Smit, E ^a   Oberholzer, H M ^a   Steyn, E ^b   Briedenhann, S ^b   Franz, R C ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Canova; Fibrin networks; HIV; Immunomodulator; Platelets

Indexed keywords

CANOVA; IMMUNOMODULATING AGENT; UNCLASSIFIED DRUG; CANOVA MEDICATION; FIBRIN; PLANT EXTRACT; SNAKE VENOM;

ANTIVIRAL RESISTANCE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; MEMBRANE RUPTURE; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOCYTE STRUCTURE; THROMBOCYTOPENIA; THROMBOSIS; VIRUS LOAD; CELL MEMBRANE; IMMUNOLOGY; PATHOLOGY; THROMBOCYTE; ULTRASTRUCTURE;

APOPTOSIS; BLOOD PLATELETS; CD4 LYMPHOCYTE COUNT; CELL MEMBRANE; CROTALID VENOMS; FIBRIN; HIV INFECTIONS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PLANT EXTRACTS; VIRAL LOAD;

EID: 63449103534     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Asres K., Seyoum A., Veeresham C., Bucar F. and Gibbons S. (2005). Naturally derived anti-HIV agents. Phytother Res. 19, 557-581.
2. Bamberg R. (2002). Segmented neutrophil size and platelet morphology in HIV/AIDS patients. Clin. Lab. Sci. 15, 18.
3. Bartlett J.A. and Muro E.P. (2007). Generic and branded drugs for the treatment of people living with HIV / AIDS. J. Int. Assoc. Physicians AIDS Care. 6, 15-23.
4. Bebert A.A., Castanheira P.T., Feliu D.G.G., Jorge A.C. and Junta M.I. (2002). A multicentric clinical survey of HIV / AIDS patients submitted to Canova immunomodulatory treatment associated with antiretroviral medications. http://www.canovadobrazil.com.br.english/works.htm
5. Bodeker G., Carter G., Burford G. and Dvorak-Little M. (2006). HIV / AIDS: Traditional systems of health care in the management of a global epidemic. J Altern Complement Med. 12, 563-576.
6. Castanheira P.T., Oliveira A.P., Rajao M.C.S., Krieger C.O.P., Modesto N.P. and Feliu D.G.G. (2002). Evaluation of Canova immunomodulator use in patients with cancer http://www.canovadobrazil.com.br.english/works/ Evaluation_of_Canova.pdf
7. Cramer E.M., Berger G. and Berndt M.C. (1994). Platelet alpha-granule and plasma membrane share two new components: CD9 and PECAM-1. Blood 84, 1722-1730.
8. Da Rocha Piemonte M. and De Freitas Buchi D. (2002). Analysis of IL-2, IFN-γ and TNF-α production, a5β1 integrins and actin filaments distribution in peritoneal mouse macrophages treated with homeopathic medicament. J. Submicrosc. Cytol. Pathol. 34, 255-263
9. das Graças Mota Silveira Sasaki M. (2001). A Placebo controlled randomized clinical survey to evaluate the efficacy and safety of the immunomodulator Canova in the therapeutics of Aids patients being administered antiretroviral medications http://www.canovadobrazil.com.br/ espanol/trabajos/ESPTC_Sasaki.doc
10. Davis B.R. and Zauli G. (1995). Effect of human immunodeficiency virus infection on haematopoiesis. Baillieres Clin. Haematol. 8, 113-130.
11. De Oliveira C.C., De Oliveira S.M., Godoy L.M.F., Gabardo J. and De Freitas Buchi D. (2006). Canova, A Brazilian medical formulation, alters oxidative metabolism of mice macrophages. J. Infect. 52, 420-432.
12. Gottlieb R.A. (2006). Apoptosis. In: Williams' Haemotology. 7th ed. Lichtman M.A., Kipps J., Kaushansky K., Beutler E., Seligsohn U. and Prehal J.T. (eds). McGraw Hill. New York.
13. Havlir D.V. and Hammer S.M. (2005). Patents versus patients? Antiretroviral therapy in India. N. Engl. J. Med. 353, 749-751.
14. King S.M. and Reed G.L. (2002). Development of platelet secretory granules. Cell Dev Biol. 13, 293-302.
15. Leissinger C.A. (2001). Platelet kinetics in immune thrombocytopenic purpura and human immunodeficiency virus thrombocytopenia. Curr. Opin. Hematol. 8, 299-305.
16. Lopes L., Godoy L.M.F., de Oliveira C.C., Gabardo J., Schadeck R.J.G. and De Freitas Buchi D. (2006). Phagocytosis, endosomal/ lysosomal system and other cellular aspects of macrophage activation by Canova medication. Micron 37, 277-287.
17. Poliakova A.M., Kravchenko A.V., Astrina O.S., Serebrovskaia L.V., Khavarova V.V., Iurin O.G., Pokrovski V.V. and Maleev V.V. (1995). The thrombocytic link in hemostasis and the immune system of patients with HIV infection. Zh. Mikrobiol. Epidemiol. Immunobiol. 3, 80-82.
18. Pretorius E., Oberholzer H.M., Smit E., Steyn E., Briedenhann S. and Franz C.R. (2008). Ultrastructural changes in platelet aggregates of HIV patients: a scanning electron microscopy study. Ultrastruct. Pathol. 32, 75-79.
19. Sato D., Wal R., de Oliveira C.C., Cataneo R.I.I., Malezzi M., Gabardo J. and Buchi D. (2005). Histopathological and immunophenotyping studies on normal and sarcoma 180-bearing mice treated with a complex homeopathic medication. Homeopathy 94, 26-32.
20. Seligmann I.C., Lima P.D.L., Cardoso P.C.S., Khayat A.S., Bahia M.O., Buchi D., Cabral I.R. and Burbano R.R. (2003). The Canova Method homeopathic compound is not genotoxic to the in vitro human lymphocytes. Genet. Mol. Res. 2, 223-228.
21. Smit E., Pretorius E., Anderson R. and Oommen J. and Potjo M. (2008). Differentiation of human monocytes in vitro following exposure to Canova in the absence of cytokines. Ultrastruct. Pathol. 32, 147-152.
22. von Hundelshausen P. and Weber C. (2007). Platelets as immune cells. Briding inflammation and cardiovascular disease. Circ. Res. 100, 27-40.
23. White J.G. (2004). Platelets are covercytes, not phagocytes. Blood 104, 3533.
24. Wyllie A.H., Kerr J.F. and Currie A.R. (1980). Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
25. Youssefian T., Drouin A., Masse J.M., Guichard J. and Cramer EM. (2002). Host-defence role of platelets: HIV and Staphylococcus aureus engulfment occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 99, 4021-4029.
26. Zauli G., Catani L., Gibellini D., Rem C., Vianelli N. and Colangeli V. (1996). Impaired survival of bone marrow GbIIb/IIIa[+] megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. Br. J. Haematol. 92, 711-717.